FAKTOR-OPTIONSSCHEIN - INMODE Share Price

Certificat

DE000ME922X8

Market Closed - Börse Stuttgart 11:57:09 28/06/2024 pm IST
0.216 EUR +20.00% Intraday chart for FAKTOR-OPTIONSSCHEIN - INMODE
Current month-43.16%
1 month-40.00%
Date Price Change
28/24/28 0.216 +20.00%
27/24/27 0.18 +4.05%
26/24/26 0.173 -16.83%
25/24/25 0.208 +0.48%
24/24/24 0.207 -4.61%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 11:57 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying INMODE LTD.
Issuer Morgan Stanley
WKN ME922X
ISINDE000ME922X8
Date issued 21/02/2024
Strike 15.81 $
Maturity Unlimited
Parity 11.1 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.28
Lowest since issue 0.136

Company Profile

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Sector
-
More about the company

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: InMode Ltd.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.24 USD
Average target price
25.6 USD
Spread / Average Target
+40.35%
Consensus